Oxurion NV Announces Share Consolidation and Key Dates

Leuven, BELGIUM – Oxurion NV, a biopharmaceutical company, confirmed that September 2, 2024, was the last trading day for its current shares on Euronext Brussels. The consolidation of shares will occur on September 3, 2024.

The share consolidation will be based on a ratio of one new share for ten thousand existing shares. This move aims to increase the par value, simplify the capital structure, and improve liquidity. Further details are available in a press release dated July 25, 2024.

The schedule for the operation includes key dates: the effective date of consolidation on September 3, 2024, and the record date for new shares delivery on September 4, 2024. Shareholders with multiples of 10,000 shares will have their holdings automatically consolidated.

Fractional shares will be managed by Financière d'Uzès. Shareholders with less than 10,000 shares need to adjust their position by August 30, 2024. Proceeds from the sale of fractional shares will be distributed by the financial intermediaries concerned.

This initiative aligns with Oxurion's long-term growth strategy, aiming to improve market perception, reduce volatility, and optimize trade. Oxurion remains committed to an optimal financial structure.